Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions

Sponsor
Carl Zeiss Meditec, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00396188
Collaborator
(none)
769
4
12
192.3
16

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    1. To establish reference values for SF, CIM, and TKM in subjects with normal corneas.

    2. To establish reference values for SF, CIM, and TKM in subjects who underwent myopic laser vision correction.

    3. To establish reference values for SF, CIM, and TKM in subjects who underwent hyperopic laser vision correction.

    4. To establish reference values for SF, CIM, and TKM in subjects who were diagnosed to have keratoconus.

    5. To establish reference values for SF, CIM, and TKM in subjects with history of orthokeratology.

    6. To establish reference values for SF, CIM, and TKM in subjects with previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface that are not listed above.

    7. To determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas using true elevation data and axial curvature.

    8. To determine the sensitivity, specificity, and accuracy of the Pathfinder II Corneal Analysis software in discriminating normal corneas from previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface (Phase II).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    769 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Corneal Analysis - Pathology Detection Aid
    Study Start Date :
    Feb 1, 2007
    Actual Primary Completion Date :
    Feb 1, 2008
    Actual Study Completion Date :
    Feb 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    Normals

    Patients seeking initial laser vision correction that were screened to be good candidates for the procedure. No history of refractive or other ocular surgery. No corneal pathologies. Normal corneal topography. Contact lens wearers should discontinue use at least 2 weeks for hard contacts, and 3 days for soft lenses prior to imaging.

    Keratoconus

    An irregular cornea determined by distorted keratometry mires, distortion of the retinoscopic, or ophthalmoscopic red reflex (or a combination of these) At least one of the following biomicroscopic signs: Vogt's striae, Fleischer's ring of >2 mm arc, or corneal scarring consistent with keratoconus. Contact lens wearers should discontinue use preferably 1 day or at least half an hour prior to imaging.

    Myopic Laser Vision Correction

    Patients who have undergone myopic: LASIK PRK LASEK

    Hyperopic Laser Vision Correction

    Patients who have undergone hyperopic: LASIK PRK LASEK

    Orthokeratology

    1. Patients using specially designed rigid contact lenses to reshape the cornea to temporarily reduce or eliminate refractive error.

    Others

    1. Corneal conditions (diseases/ pathologies/surgeries) that can potentially affect the corneal surface that are not listed above (e.g. pellucid marginal degeneration; postoperative corneal transplant, intra-corneal ring segments, refractive keratotomy, conductive keratoplasty; peripheral ulcerative keratitis, Terrien's marginal degeneration; etc.).

    Outcome Measures

    Primary Outcome Measures

    1. Reference values of normal and previously diagnosed corneal conditions by Atlas II corneal topographer [1-2 hours]

    Secondary Outcome Measures

    1. Repeatabiltity and reproducibility of the Atlas II corneal topographer in human corneas [1-2 hours]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Normals

    • Patients seeking initial laser vision correction that were screened to be good candidates for the procedure.

    • No history of refractive or other ocular surgery.

    • No corneal pathologies.

    • Normal corneal topography.

    • Contact lens wearers should discontinue use at least 2 weeks for hard contacts, and 3 days for soft lenses prior to imaging.

    Keratoconus

    • An irregular cornea determined by distorted keratometry mires, distortion of the retinoscopic, or ophthalmoscopic red reflex (or a combination of these)

    • At least one of the following biomicroscopic signs: Vogt's striae, Fleischer's ring of

    2 mm arc, or corneal scarring consistent with keratoconus.

    • Contact lens wearers should discontinue use preferably 1 day or at least half an hour prior to imaging.

    Myopic Laser Vision Correction

    Patients who have undergone myopic:
    • LASIK

    • PRK

    • LASEK

    Hyperopic Laser Vision Correction

    Patients who have undergone hyperopic:
    • LASIK

    • PRK

    • LASEK

    Orthokeratology

    • Patients using specially designed rigid contact lenses to reshape the cornea to temporarily reduce or eliminate refractive error.

    • Subjects must be 18 years of age or older; able and willing to make the required visit; and able and willing to give consent.

    Exclusion Criteria:
    • Patients that underwent corneal transplantation or any ocular surgery for the following categories: normal, keratoconus, and orthokeratology)

    • Any active infection or inflammation of the cornea.

    • PI decides that subject is not suitable due to medical risk.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shiley Eye Center-University of California San Diego La Jolla California United States 92093
    2 Carmel Mountain Vision Care Center San Diego California United States 92129
    3 Dishler Laser Institute Greenwood Village Colorado United States 80111
    4 Pacific University Forest Grove Oregon United States 97116

    Sponsors and Collaborators

    • Carl Zeiss Meditec, Inc.

    Investigators

    • Principal Investigator: Jon Dishler, M. D., Dishler Laser Institute
    • Principal Investigator: David J Schanzlin, M. D., Shiley Eye Center-University of California San Diego
    • Principal Investigator: Dennis Burger, O. D., Kaiser Permanente, Oakland
    • Principal Investigator: Patrick Caroline, COT, Pacific University
    • Principal Investigator: Tyson Brunstetter, O. D., Naval Training Center-Refractive Surgery Clinic
    • Principal Investigator: Kevin Reeder, O.D., Carmel Mountain Vision Care Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Carl Zeiss Meditec, Inc.
    ClinicalTrials.gov Identifier:
    NCT00396188
    Other Study ID Numbers:
    • Atlas II-2006-1-v1
    First Posted:
    Nov 6, 2006
    Last Update Posted:
    Aug 17, 2015
    Last Verified:
    Aug 1, 2015

    Study Results

    No Results Posted as of Aug 17, 2015